Gamal Esmat

Dr. Gamal Esmat is a leading academic and researcher in hepatology, currently affiliated with the Faculty of Medicine at Cairo University and Badr University in Cairo. He has held key roles at Cairo University Hospitals and the National Committee for Control of Viral Hepatitis, contributing extensively to medical education and public health policy in Egypt.

His research focuses on chronic hepatitis C, liver diseases, and innovative antiviral therapies. He has conducted numerous randomized controlled trials and published in top-tier journals such as Journal of Hepatology and Arab Journal of Gastroenterology. His work bridges clinical research and public health, with strong emphasis on treatment efficacy and socio-economic impacts of national health programs.

Dr. Esmat's recent publications show a sustained focus on HCV treatment optimization, genetic factors in viral susceptibility, and molecular mechanisms of liver disease. His research trends reflect deep engagement with clinical trials, biomarker analysis, and translational hepatology.

He has received funding and collaborated with prestigious international sponsors including the Japan Society for the Promotion of Science, the Bill and Melinda Gates Foundation, National Institutes of Health, and Gilead Sciences, underscoring the global relevance of his work.

Dr. Esmat has advised numerous students and researchers in hepatology and liver disease, though specific names are not listed. His leadership in national and institutional research initiatives highlights his role in mentoring and guiding the next generation of medical scientists in Egypt.

He is actively involved in research teams focused on viral hepatitis, working within networks that include the Egyptian Association for the Study of Liver and Gastrointestinal Diseases and multi-country collaborations. His work is supported by institutional labs and clinical research units at Cairo University and affiliated hospitals.